Clinical trials: CDKL5, open to volunteers

Dravet Syndrome

The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

• Recruiting
• Age: 16 years and older
• Phase 4
• Medical device

This study investigates cerebrovascular reactivity (CVR) and functional brain connectivity in Dravet Syndrome (DS) patients with convulsive seizures.

Trial name

FAST-DS (NCT07112365)

Testing

Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct)

Where

United States

Volunteers

25 people

Sponsor

The University of Texas Health Science Center, Houston